Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 30fludarabine 20fludarabine phosphate 13Methotrexate 13blinatumomab 11Whole-Body Irradiation 11Vincristine 9Tacrolimus 8Mycophenolic Acid 8Dexamethasone 8Cytarabine 8Specimen Handling 7Mercaptopurine 7Cyclosporine 7Busulfan 7merphos 6Thiotepa 6Melphalan 6Granulocyte Colony-Stimulating Factor 6pegaspargase 5Stem Cell Transplantation 5Prednisone 5Peripheral Blood Stem Cell Transplantation 5Mesna 5Leukapheresis 5Immunotherapy, Adoptive 5Filgrastim 5Biopsy 5venetoclax 4prednylidene 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Medrol Veriderm × 30 days × Clear all
NCT00792948 2026-05-29

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
97 enrolled 7 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡